A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough Levels

A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough Levels

BACKGROUND: Although infliximab is an effective therapy for inflammatory bowel disease (IBD), it is associated with dermatological events and infusion reactions. It is not known whether a relationship between these adverse events (AEs) and infliximab trough levels (ITLs) exists.

Bibliographic Details
Main Authors:	Vivian Wai-Mei Huang, Neil Dhami, Darryl Fedorak, Connie Prosser, Carol Shalapay, Karen Ivy Kroeker, Brendan Phillip Halloran, Levinus Albert Dieleman, Richard Neil Fedorak
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	Canadian Journal of Gastroenterology and Hepatology
Online Access:	http://dx.doi.org/10.1155/2015/428702

Similar Items

Inflammatory Bowel Disease Patients Are Frequently Nonadherent to Scheduled Induction and Maintenance Infliximab Therapy: A Canadian Cohort Study
by: Christopher Ma, et al.
Published: (2015-01-01)

Long-Term Response Rates to Infliximab Therapy for Crohn’s Disease in an Outpatient Cohort
by: Christopher W Teshima, et al.
Published: (2009-01-01)

Infusion reaction to infliximab biosimilar after transitioning from infliximab
by: Reem Kashlan, MPH, et al.
Published: (2021-02-01)

Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
by: Neeraj Narula, et al.
Published: (2009-01-01)

Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab.
by: Dario Sorrentino, et al.
Published: (2015-01-01)

The Safety of Infliximab Infusions in the Community Setting
by: James Ducharme, et al.
Published: (2010-01-01)

Early infliximab antibody testing does not prevent infusion reactions when reinitiating infliximab
by: Joseph D. Feuerstein
Published: (2016-08-01)

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
by: van der Maas Aatke, et al.
Published: (2012-09-01)

Acute Phase Reaction After Infliximab Infusion
by: Ozan Ünlü, et al.
Published: (2019-09-01)

Psoriasiform paradojic reaction associated with infliximab infusion
by: Lorena De Agustín Sierra
Published: (2017-07-01)

Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis
by: Remo Panaccione, et al.
Published: (2008-01-01)

Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy
by: Dustin E Loomes, et al.
Published: (2011-01-01)

Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation
by: Fernando Magro, et al.
Published: (2017-07-01)

Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
by: Fazia A. Mir, et al.
Published: (2018-02-01)

Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion
by: Jozélio Freire de Carvalho, et al.
Published: (2018-08-01)

Switch from Infliximab to Infliximab-dyyb for Rheumatology Indications
by: Alexi Spoto, et al.
Published: (2021-05-01)

Serum-Infliximab Trough Levels in 45 Children with Inflammatory Bowel Disease on Maintenance Treatment
by: Helena Rolandsdotter, et al.
Published: (2017-03-01)

Infliximab Trough Levels and Quality of Life in Patients with Inflammatory Bowel Disease in Maintenance Therapy
by: Rogério S. Parra, et al.
Published: (2018-01-01)

Similar Clinical and Surgical Outcomes Achieved with Early Compared to Late Anti-TNF Induction in Mild-to-Moderate Ulcerative Colitis: A Retrospective Cohort Study
by: Christopher Ma, et al.
Published: (2016-01-01)

Do plasticized polyvinylchloride and polyurethane infusion sets promote infliximab adsorption?
by: Chennell Philip, et al.
Published: (2020-05-01)

Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab
by: Fitzgerald T, et al.
Published: (2021-01-01)

Uso de infliximabe na policondrite recidivante Infliximab in relapsing polychondritis
by: Ana Paula Soares de Barros, et al.
Published: (2010-04-01)

Hidradenite supurativa tratada com infliximabe Hidradenitis suppurativa treated with infliximab
by: Daniel Lago Obadia, et al.
Published: (2009-12-01)

Infliximab in Crohn's disease Infliximab en la enfermedad de Crohn
by: L. Rodrigo Sáez
Published: (2004-06-01)

Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
by: Subedi S, et al.
Published: (2019-07-01)

Clinical Experience with Infliximab for Crohn’s Disease: The First 100 Patients in Edmonton, Alberta
by: Clifford Sample, et al.
Published: (2002-01-01)

Infliximab in Crohn's disease
by: L. Rodrigo Sáez

Infliximab in ulcerative colitis
by: Avi Levin, et al.
Published: (2008-09-01)

Uso de infliximabe em vasculite reumatóide Infliximabe use in rheumatoid vasculitis
by: Manoel Barros Bértolo
Published: (2007-08-01)

Tratamento de hidradenite supurativa com infliximab Treatment of hidradenitis suppurativa with infliximab
by: Tiago Torres, et al.
Published: (2010-08-01)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn’s Disease
by: Luis Eduardo Miani Gomes, et al.
Published: (2019-04-01)

Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study
by: Akihiro Koga, et al.
Published: (2018-04-01)

Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study
by: Ido Veisman, et al.
Published: (2021-09-01)

Infliximab no tratamento da artrite psoriásica grave Infliximab in treatment of severe psoriatic arthritis
by: Adriano Jaime Consorte Loyola, et al.
Published: (2005-10-01)

Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding Varies Widely: A Need for Further Education
by: Vivian Wai-Mei Huang, et al.
Published: (2016-01-01)

Infliximab in Russian clinical practice
by: G V Lukina, et al.
Published: (2012-09-01)

Therapy for psoriatic arthritis with infliximab
by: V V Badokin, et al.
Published: (2009-03-01)

Infliximab in the therapy of rheumatoid arthritis
by: G. V. Lukina, et al.
Published: (2016-05-01)

Infliximab in inflammatory bowel disease
by: Konstantinos Papamichael, et al.
Published: (2019-03-01)

Infliximab for the treatment of ulcerative colitis
by: C Hyde, et al.
Published: (2009-10-01)

Cannot write session to /tmp/vufind_sessions/sess_reqpems2jsqv15585tucmovrhm